Viemed Healthcare, Inc. provided earnings guidance for the first quarter of 2024. For the quarter, the company expects to generate net revenues of approximately $49.7 million to $51.0 million during the first quarter of 2024 and assumes that the 75/25 blended Medicare reimbursement rate adjustment in non-rural, non-competitive bid areas is not extended.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.145 USD | +0.21% | -12.65% | -8.98% |
07/05 | Transcript : Viemed Healthcare, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
06/05 | Earnings Flash (VMD) VIEMED HEALTHCARE Reports Q1 Revenue $50.6M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.98% | 277M | |
+20.68% | 85.55B | |
-29.31% | 70.07B | |
+9.65% | 29.06B | |
-8.63% | 17.51B | |
+2.14% | 17.39B | |
+0.39% | 15.38B | |
+6.47% | 13.4B | |
+68.09% | 12.87B | |
+6.43% | 12.77B |
- Stock Market
- Equities
- VMD Stock
- News Viemed Healthcare, Inc.
- Viemed Healthcare, Inc. Provides Earnings Guidance for the First Quarter of 2024